According to the new market research report "Mycoplasma
Testing Market by
Product & Services (Kits & Reagent and Instruments), Technique (PCR,
ELSA, Enzymatic Methods, and DNA Staining), Application (Cell Line Testing and
Virus Testing), End User (Pharmaceutical Companies and Cell Banks) - Global
Forecast to 2022", published by MarketsandMarkets™, analyzes and studies the major market
drivers, restraints/challenges, and opportunities.
Don’t miss out on business opportunities in Mycoplasma Testing Market.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=136509856
Don’t miss out on business opportunities in Mycoplasma Testing Market.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=136509856
The increasing growth of
government support for pharmaceutical and biotechnology industries, rising
R&D activities in life sciences research, and rising cell culture contamination
are expected to drive the growth of this market.
The global market is segmented by
product, technique, application, end user, and region. By product, the market
is segmented into kits & reagent, services, and instruments. The kits &
reagent segment is expected to lead the global market in 2017. The frequent
purchase of these consumables as compared to instruments and increasing use of
kit-based techniques are the key factors driving the growth of this segment.
On the basis of technique, the market
is classified into PCR, ELISA, direct assays, indirect assays, DNA staining,
microbial culture techniques, and enzymatic methods. The PCR segment is
expected to account for the largest share of the market in 2017 due it the high
acceptance rate of PCR, which can be attributed to its accuracy, speed, and
flexibility in life sciences research.
Browse and in-depth TOC on " Mycoplasma Testing Market”
73 – Tables
36 – Figures
156 – Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/mycoplasma-testing-market-136509856.html
73 – Tables
36 – Figures
156 – Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/mycoplasma-testing-market-136509856.html
On the basis of application, the mycoplasma testing market is segmented
into cell line testing, virus testing, end-of-production cell testing, and
other applications. Cell line testing segment accounts for the largest segment
and is also the fastest growing application segment in the market. Increasing
use of cell lines for research and biopharmaceutical production is the major
factor driving the growth of this market.
On the basis of end users, the equipment market is segmented into
pharmaceutical and biotechnology companies, academic research institutes,
contract research organizations (CROs), cell banks, and other end users. In
2017, the pharmaceutical & biotechnology companies’ segment is expected to
account for the largest share and is projected to register the highest rate
during the forecast period. R&D investments in the pharmaceutical industry
are one of the major factors fueling the growth of this segment.
Request for Free
Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=136509856
The global mycoplasma testing market is dominated by North
America, followed by Europe. North America will continue to dominate the global
market during the forecast period. However, Asia is expected to witness the
highest CAGR, with the growth in this market centered at China, Japan, and
India. The increase in generics development and manufacturing is a major growth
driver for the pharmaceutical industry in this region. Growing government
investments in pharmaceutical R&D and the increasing trend of
pharmaceutical outsourcing are some factors propelling market growth in the
Asian region.
Major industry players expand across geographies via partnerships
and acquisitions in the future. Thermo Fisher Scientific Inc., Lonza Group
Ltd., Merck KGaA, and Charles River Laboratories International Inc. have been
identified as the top players in this market. These companies have a broad
product portfolio with comprehensive features. These companies have products
for all end users in this segment, a strong geographical presence, and more
importantly, focus on continuous product innovations.
Comments
Post a Comment